The Pentagon's Human Performance Programs

The US military has a practical problem with human cognition. Soldiers make decisions under conditions that degrade every cognitive system the brain relies on: sleep deprivation, caloric deficit, sustained fear, sensory overload, and time pressure. The decisions they make under those conditions determine outcomes. The Pentagon has funded research into modifying those conditions, or the brain's response to them, since at least the 1980s.

The programs that emerged from that funding are partially documented. Their existence is not secret. Their goals are described in publicly available budget documents, congressional testimony, and academic papers produced by researchers working under government contracts. What is not fully available is the cumulative result of decades of research into what can actually be done to a human brain under controlled conditions to make it perform differently.

DARPA's Continuous Assisted Performance program, active in the early 2000s, investigated whether soldiers could be kept cognitively functional for extended periods without sleep. The program's stated goal was to eliminate the need for sleep for up to seven days without degradation in cognitive performance. This is not a modest goal. Sleep deprivation at 72 hours produces psychotic symptoms in otherwise healthy individuals. The program was asking whether pharmacological or other interventions could maintain baseline function across that range.

Some of the research the program funded was published. Modafinil, a wakefulness-promoting drug, was studied for its ability to maintain cognitive performance in sleep-deprived subjects. The results showed measurable but incomplete effects: modafinil could sustain wakefulness and reduce some performance decrements but could not fully prevent the cognitive degradation associated with extended sleep deprivation. The research that went beyond modafinil into other pharmacological and non-pharmacological approaches was not fully published.

The program was terminated without a public announcement of what its seven-day target actually required or whether it was achieved. The research it funded continued in subsequent programs under different names.

The Army's Peak Soldier Performance program examined whether soldiers' cognitive and physical performance could be enhanced through nutritional and metabolic interventions. The program studied how specific nutritional protocols, including ketogenic diets and targeted supplementation, affected decision-making speed, working memory, and physical endurance under stress.

This research produced published findings. Some nutritional interventions showed measurable effects on specific cognitive metrics. The research also produced findings that were not published. The gap between the published results and the program's full scope can be estimated from the budget allocations, which significantly exceeded what would be required to produce only the published output.

The Accelerated Learning program, discussed in the DARPA neural interface context, is also relevant here as a human performance program. Its investigation of transcranial direct current stimulation as a tool for accelerating skill acquisition represents the intersection of neural intervention and the military's practical need to produce competent personnel faster than conventional training allows.

The published findings from tDCS research under this program are inconclusive. The unpublished findings cover a range of stimulation approaches that went beyond tDCS. Several research institutions produced results under Accelerated Learning contracts that did not appear in peer-reviewed literature. Whether those results were negative, which would explain their absence, or positive but withheld, which would explain the continued program funding, is not established by any available document.

A separate thread of military human performance research focused not on enhancing baseline cognitive capacity but on preserving decision-making quality under the specific stressors of combat. The Office of Naval Research funded research into how cortisol, adrenaline, and other stress hormones affect executive function, risk assessment, and working memory in experienced versus inexperienced decision-makers.

This research produced a significant finding: expertise does not protect against stress-induced cognitive degradation in the same way across all domains. Experienced soldiers showed preserved performance on well-practiced tasks under stress but showed comparable degradation to novices on novel problem-solving. The implication is that training alone cannot produce stress-resilient decision-making in genuinely novel situations. An intervention at the neurochemical level would be required.

Whether programs investigating such interventions were funded is not fully established in the public record. That the research leading to that conclusion was funded and published suggests the logical next step was also funded. Whether it was published is a separate question.

The US military's use of pharmacological cognitive enhancement is partially documented in the public record. Amphetamines were issued to military pilots in World War II, Korea, Vietnam, and Gulf War operations. Modafinil replaced amphetamines as the preferred wakefulness agent in the 2000s. Go pills, the informal name for dextroamphetamine issued to combat pilots, were the subject of a high-profile incident in 2002 when Canadian soldiers were killed by US pilots who had taken them. The subsequent investigation confirmed the military's pharmacological enhancement program in that context.

What the investigation did not address was the broader pharmacological research program that produced those protocols. The specific drugs in use at any given time represent the endpoint of a research process. The research process that evaluated which drugs to use, at what doses, under what conditions, and with what neurological mechanisms has not been fully documented in the public record.

The Pentagon has spent decades researching how to make human brains perform differently under conditions that degrade them. The programs are real, partially documented, and ongoing. The published findings consistently show partial effects that do not fully account for the funding levels and program durations. The full scope of what these programs found, across pharmacological, electrical, nutritional, and neural intervention categories, is not in the public record.